NCT05369936 - Pain Perception: on Relationships Between Dental Anxiety and Olfaction | Crick

Overview

the objective of this study is to evaluate the ability of olfaction in obtaining positive emotional and behavioral responses toward dental anxiety and pain in patients undergoing different dental procedures.

All patients who meet inclusion criteria of the study will be given a written consent and enrolled into a randomized double-blinded controlled study (investigator and patients are blinded about the study). Patients will be divided into lavender and control groups. Patients in lavender group will subjected 2 % lavender vapors. In control group, patients will inhale distal water vapors

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

350

Conditions

Dental Anxiety Dental Pain Essential Oil

Interventions

AromatherapyOTHER

Lavender will be inhaled through three phases

PlaceboOTHER

Vapors of the distal water will be inhaled through three phases

Eligibility

Sex: FEMALEMin age: 19 YearsMax age: 25 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adult females over 18 years, 2. Attending morning sessions of clinics (9 am) 3. Liable for administration of local anesthesia, tooth preparation either for filling procedures or crown preparations, endodontic treatment, teeth extraction, or subgingival scaling Exclusion Criteria: 1. Males 2. Females who had allergies, bronchial asthma, common cold, pulmonary diseases, migraine, or taking antidepressants, anxiolytic drugs, opioids, or other medications that affect our results

Locations (1)

Ghada Amin Khalifa

Buraidah, Buraydah, Saudi Arabia

Outcomes

Primary Outcomes

Anxiety score

This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety

Time frame: 20 minutes before exposure to vapors

Anxiety score

This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety

Time frame: 20 minutes After exposure to vapors

Anxiety score

This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety

Time frame: 24 hours After exposure to vapors

Secondary Outcomes

Pain Score

A person rates their pain on a scale of 0 to 10 Zero means "no pain," 1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain

Time frame: 20 minutes before exposure to vapors

Pain Score

A person rates their pain on a scale of 0 to 10 Zero means "no pain," 1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain

Time frame: 20 minutes after exposure to vapors

Pain Score